Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard? David M. Taylor Editorial 03 March 2017 Pages: 177 - 180
Binge Drinking: Current Diagnostic and Therapeutic Issues Benjamin RollandMickaël Naassila Current Opinion 15 February 2017 Pages: 181 - 186
Nogo-A Antibodies for Progressive Multiple Sclerosis Benjamin V. IneichenPatricia S. PlattnerMartin E. Schwab Leading Article 19 January 2017 Pages: 187 - 198
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine Leonie HennissenMireille J. BakkerThe ADDUCE consortium Systematic Review Open access 24 February 2017 Pages: 199 - 215
Outcome Measures in Clinical Trials for Multiple Sclerosis Caspar E. P. van MunsterBernard M. J. Uitdehaag Review Article Open access 09 February 2017 Pages: 217 - 236
Impact of Drug Manipulation on Seizure Freedom in Adults with Uncontrolled Epilepsy: A Prospective Controlled Study in Rural China Xiaoting HaoZiyi ChenDong Zhou Original Research Article 22 November 2016 Pages: 237 - 243
Benzodiazepine Use and Risk of Developing Alzheimer’s Disease: A Case-Control Study Based on Swiss Claims Data Fabienne A. BiétryAlena M. PfeilChristoph R. Meier Original Research Article 11 January 2017 Pages: 245 - 251